瑞典药物递送公司Nanexa的股价在周五早盘交易中翻了一倍多，此前该公司与诺和诺德签署了一项全球许可协议，价值高达约11.7亿欧元（13.3亿美元）。
Shares in Swedish drug-delivery company Nanexa more than doubled their value in early Friday trading after it signed a global licensing deal with Novo Nordisk worth up to about €1.17 billion ($1.33 billion).